Nuvation Bio NUVB Translation Adjustment Functional To Reporting Currency Tax Expense Benefit
Translation Adjustment Functional To Reporting Currency Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyTaxExpenseBenefit.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's translation adjustment functional to reporting currency tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's translation adjustment functional to reporting currency tax expense benefit?
- Nuvation Bio (NUVB) reported translation adjustment functional to reporting currency tax expense benefit of $268K in Q1 2026.
- How has Nuvation Bio's translation adjustment functional to reporting currency tax expense benefit changed year-over-year?
- Nuvation Bio's translation adjustment functional to reporting currency tax expense benefit increased by 157.6% year-over-year, from -$465K to $268K.
- What does translation adjustment functional to reporting currency tax expense benefit mean?
- This metric represents the impact of exchange rate fluctuations on the translation of financial statements from a functional currency to the company's reporting currency. It captures the unrealized gains or losses arising from the conversion of foreign-denominated assets and liabilities. This provides insight into the company's exposure to foreign currency risk and the volatility of its international operations.